Parmantier & Cie. Reiterates Buy on Wacker Chemie With €106 Price Target

By Public Technologies
  • Parmantier & Cie. reiterated Buy on Wacker Chemie on November 5, 2026, keeping its price target at €106.
  • The analysts forecast EBITDA of €790 million for 2027, rising to €854 million in 2028.
  • They expect fourth-quarter results to exceed conservative guidance, with the investment case centered on recovery in Silicones and Polymers.
  • The firm's base case assumes €500 million in net cash in 2027, an independent estimate rather than company guidance.
  • Sum-of-the-parts scenarios imply approximately €120 per share adjusted for valuation timing, or €129 on a nominal 2028 basis, not formal targets.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wacker Chemie AG published the original content used to generate this news brief via EQS News (Ref. ID: rc_27324) on November 05, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.